MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
4.240
+0.100 (2.42%)
At close: Dec 20, 2024, 4:00 PM
4.241
0.00 (0.01%)
After-hours: Dec 20, 2024, 4:01 PM EST
MaxCyte Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MaxCyte stock have an average target of 9.50, with a low estimate of 8.00 and a high estimate of 11. The average target predicts an increase of 124.06% from the current stock price of 4.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 23, 2024.
Analyst Ratings
The average analyst rating for MaxCyte stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +159.43% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +159.43% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +88.68% | Mar 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +65.09% | Nov 29, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +183.02% | Oct 5, 2023 |
Financial Forecast
Revenue This Year
38.32M
from 41.29M
Decreased by -7.20%
Revenue Next Year
46.46M
from 38.32M
Increased by 21.27%
EPS This Year
-0.42
from -0.37
EPS Next Year
-0.40
from -0.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 39.6M | 49.8M | 65.7M | |||
| Avg | 38.3M | 46.5M | 58.4M | |||
| Low | 36.6M | 42.1M | 51.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -4.1% | 29.9% | 41.4% | |||
| Avg | -7.2% | 21.3% | 25.6% | |||
| Low | -11.4% | 10.0% | 11.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.42 | -0.36 | -0.30 |
| Avg | -0.42 | -0.40 | -0.36 |
| Low | -0.42 | -0.45 | -0.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.